Hospital Launches Center for Childhood Cancer Research


The Children's Hospital of Philadelphia, through the Joseph Stokes Jr. Research Institute, has launched a bold initiative aimed at curing more patients with childhood cancer by using more precise, and therefore less toxic, therapies.

The Center for Childhood Cancer Research is a new Center of Emphasis at the Stokes Institute and represents a highly integrated basic, translational and clinical research environment dedicated to eradicating the pain and suffering caused by cancer in children. This goal will be realized by bringing together the diverse talents of investigators in the Hospital's renowned multidisciplinary program in pediatric cancer research, patient care and genomics.

The Center's organization supports an environment where basic scientists will interact with master clinicians around the central theme of improving cure rates through translational research initiatives. Recruitment of leading talent in areas that can facilitate this progress, spanning the laboratory and clinical research ends of the spectrum, will enable the Center's mission. Key to the Center's success is translating the latest scientific findings obtained from cutting-edge basic research into innovative clinical trials designed to dramatically improve the cure rates for pediatric cancers while simultaneously eliminating long-term side effects.

John Maris, M.D., will serve as the inaugural director of the Center for Childhood Cancer Research. An internationally recognized expert in pediatric oncology, Dr. Maris has a longstanding research program that typifies the phrase "bench to bedside." As Center director, Dr. Maris will work in close collaboration with Garrett Brodeur, M.D., Chief of the Division of Oncology, and the entire faculty within the Division of Oncology to realize the Center's vision.